Pfizer Signs $3.2B COVID Vax Deal With US

Published on June 29, 2022

Pfizer and BioNTech have just hit the jackpot! They recently sealed a staggering $3.2 billion agreement with the U.S. government for 105 million doses of their COVID-19 vaccine. It’s like striking gold in a coronavirus mine! The doses are set to be delivered in late summer, acting as an arsenal for the battle against the ongoing pandemic. This deal will provide a massive boost to nationwide vaccination efforts, potentially reaching more people and speeding up the end of the pandemic. Pfizer and BioNTech have been trailblazers in vaccine development and distribution, consistently delivering effective shots. With this new deal, they are ramping up their production to ensure even wider access to the life-saving vaccine. It’s great news for everyone as we strive toward achieving herd immunity and getting back to our normal lives. To learn more about this landmark deal, check out the full article!

Pfizer Inc. and BioNTech said Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine for delivery as soon as late summer this year.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>